Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study. - Young G; Kavakli K; Klamroth R; Matsushita T; Peyvandi F; Pipe SW; Rangarajan S; Shen MC; Srivastava A; Sun J; Tran H; You CW; et al. (Blood, 2025)